Search clinical trials for: Lymphocytic Leukemia

Total 8986 results

Rambam Health Care Campus
Miltenyi Biomedicine GmbH

Unknown

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Philadelphia Chromosome-positive Chronic Myelocytic Leukemia

Israel
Nantes University Hospital
Hoffmann-La Roche; French Innovative Leukemia Organisation

Completed

High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

B-Cell Lymphoma

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

Leukemia, Myelocytic, Acute
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

Healthy

United States
University Hospital Muenster
Bayer

Completed

Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML

Acute Myeloid Leukemia

Germany
University of Bologna
Janssen-Cilag Ltd.

Unknown

Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia (HEMOS AML 0106)

Acute Myeloid Leukemia

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Leukemia, Myelocytic, Acute | Infusions, Intravenous
Amgen

Completed

Treatment for Subjects With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Breast Cancer | Leukemia, Myeloid, Chronic

Poland
University Hospital, Motol

Unknown

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Leukemia

Czech Republic
Oxford University Hospitals NHS Trust

Unknown

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Myelodysplastic Syndromes | Leukemia

United Kingdom
Acute Leukemia French Association
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2 (ALFA 9801)

Acute Myeloid Leukemia

France
Hadassah Medical Organization

Unknown

Infections in Pediatric Cancer Patients

Infections
French Innovative Leukemia Organisation
Novartis; Schering SA

Completed

GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly

Acute Myeloid Leukemia

France
Office of Rare Diseases (ORD)
Rare Diseases Clinical Research Network

Unknown

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
PETHEMA Foundation

Completed

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Spain
Sanofi

Terminated

Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia

Myeloid Leukemia

United States, France, Spain
PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
CASI Pharmaceuticals, Inc.

Completed

A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies

Myelodysplasia | Hematological Malignancies | Agnogenic Myeloid Metaplasia

Canada
Acute Leukemia French Association
Hospices Civils de Lyon

Completed

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia
Sanofi

Completed

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Hyperuricemia | Tumor Lysis Syndrome | Tumors

United States
Sanofi

Completed

Rasburicase for Hyperuricemia

Nutritional and Metabolic Diseases

Japan
AstraZeneca

Completed

A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

Erosive Esophagitis
AstraZeneca

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Erosive Esophagitis
French Innovative Leukemia Organisation
Amgen

Completed

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas (073)

Lymphoma

France
Millennium Pharmaceuticals, Inc.

Completed

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
University Hospital Freiburg

Completed

Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Germany, Netherlands
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Symptomatic Gastroesophageal Reflux Disease (sGERD)
AstraZeneca

Completed

PPI Sequencing Study

Gastro-Oesophageal Reflux Disease

United Kingdom
Pusan National University Hospital

Available

The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder

Chronic Myeloid Leukemia
Tehran University of Medical Sciences

Completed

Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide

Leukemia, Myeloid, Acute

Iran, Islamic Republic of
Hadassah Medical Organization
United States Department of Defense

Completed

Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

Chronic Myeloid Leukemia

Israel
University Health Network, Toronto
GlaxoSmithKline; H. Lundbeck A/S

Completed

Memory Functioning and Antidepressant Treatment

Depression | Major Depressive Disorder

Canada
University Health Network, Toronto
Novartis; Mount Sinai Hospital, Canada; Princess Margaret Hospital, Canada

Terminated

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib (GIST)

Chronic Myeloid Leukemia | Chromosome Abnormality | Gastrointestinal Stromal Cell Tumors

Canada
Complejo Hospitalario Xeral-Calde
LEO Pharma

Completed

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Acute Pulmonary Embolism

Spain
St. Jude Children's Research Hospital

Completed

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Lymphoma, Non-Hodgkin | Hodgkin Disease | Chronic Myeloid Leukemia | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Myelodysplastic Syndrome (MDS) | Secondary AML | Juvenile Myelomonocytic Leukemia (JMML) | Secondary MDS

United States
French Innovative Leukemia Organisation
Hoffmann-La Roche

Completed

Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

Mantle Cell Lymphoma

France
Assistance Publique - Hôpitaux de Paris
Chiron Corporation

Unknown

Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 (Elam02)

Leukemia

France
University of Ulm

Completed

Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result

Acute Myeloid Leukemia

Germany, Austria
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); Cancer and Leukemia Group B

Completed

Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma

Lymphoma
European Organisation for Research and Treatment...

Unknown

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Leukemia

Belgium, France, Netherlands, Portugal, Italy, Croatia, Turkey
Ann & Robert H Lurie Children's Hospital of Chicago
Astex Pharmaceuticals, Inc.

Completed

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

Graft vs Host Disease

United States
Nantes University Hospital

Completed

High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)

AML

France
St. Jude Children's Research Hospital

Completed

Stem Cell Transplantation for Patients With Hematologic Malignancies

Juvenile Myelomonocytic Leukemia | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphoblastic Leukemias | Acute Myelocytic Leukemia | Hemoglobinuria, Paroxysmal

United States
MedImmune LLC

Completed

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Leukemia

United States, Israel
St. Jude Children's Research Hospital

Completed

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Acute Myeloid Leukemia | Leukemia | Hodgkin's Lymphoma | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Paroxysmal Nocturnal Hemoglobinuria

United States
Turkish Leukemia Study Group

Completed

Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML (TLG-AML-95-002)

AML
OncoVista, Inc.
AAIPharma

Unknown

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Refractory TdT-Positive Leukemia

United States

3

Subscribe